working

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

More Content

More Content

FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis

Companies: FibroBiologics, Inc.

Expect Sales To Accelerate The Next Two Years As New Products Gain Traction, Plasma Collection Centers Ramp; Clinical Trial For AATD Drug On Track For 2028 Approval; Maintain $13 Price Target

Companies: Kamada Ltd

FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25

Companies: FibroBiologics, Inc.

REVB: Gemini Results to be Released Soon

Companies: Revere Bank (REVB:NYSE)Revelation Biosciences, Inc. (REVB:NAS)

FBLG: On Target to Initiate Phase 1/2 Trial in 2025

Companies: FibroBiologics, Inc.

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top